INTRODUCTION
In 2003, complete sequences of the human genome were decoded by the human genome sequencing project (1) . In postgenomic research, one of the most essential subjects is the functional and structural analysis of gene products (proteins). As access to full-length cDNA clones is critical for such work, many projects, such as the FLJ project (2, 3) , the Kazusa cDNA project (4), the US Mammalian Gene Collection (MGC) program (5), German (6), Chinese (7) and other cDNA projects have been executed to isolate as many full-length cDNAs with as high quality as possible. For comprehensive and high-throughput expression of human proteins, both full-length cDNA clones and a versatile system for using these clones are essential. For functional analysis of proteins, one often needs to fuse various tags at either the N-or C-termini, to adjust the reading frames of the open reading frame (ORF) and tags or to locate adequate regulatory sequences [promoters, enhancers, internal ribosomal entry sites (IRESes), etc.] close to the ORF. These manipulations can be extremely difficult when a large number of clones are being handled. The Gateway cloning system (Invitrogen, CA, USA) is based on versatile expression vectors and has the potential to overcome these barriers (8) . We have therefore adopted Gateway technology and constructed 33 275 human Gateway entry clones that will serve as key resources for this versatile system. Sequence information of Gateway entry clones can be retrieved from the Human Gene and Protein Database (HGPD, http://www.HGPD.jp or http://HGPD.lifesciencedb.jp/) (Figure 1 ). ORFDB (http://orf.invitrogen.com/) (9) and the ORFeome collaboration (http://www.orfeomecolla boration.org/html) have been published as similar resources. Entry clones in ORFDB are only N-types which have a stop codon at the end of the ORF and are primarily dedicated for native or N-terminal fusion proteins, although one could produce native or C-terminalfused protein with suppression technology (10). Lamesch et al. (11) have reported on the construction of 12 212 entry clones with which the ORFeome collaboration was formed. Since a large fraction of ORFeome clones are F-types that delete the stop codon for C-terminal fusion proteins, proteins that possess a functional domain at the C-terminus might not have full biological activity when expressed based on these clones. Therefore, one might need both N-and F-type entry clones. In our collection, both types have been prepared for 11 774 cDNAs, which means that our collection may have more flexibility for various in vitro and in vivo experiments.
Utilizing these clones with a highly efficient cell-free protein synthesis system featuring wheat germ (12), we have produced and analyzed 13 364 human proteins in vitro. The expression data can be retrieved from HGPD ( Figure 1 
DATABASE CONTENTS
In HGPD, biological data such as in vitro expression data of human proteins are presented on the frame of cDNA clusters. To build the basic frame, sequences of FLJ cDNAs and others deposited in public databases (Human ESTs, RefSeq, Ensembl, MGC, etc.) are assembled onto the genome sequences (Table 1) . Information for human Gateway entry clones is presented with the source cDNAs. The specific features of the HGPD that we would like to emphasize are that it contains (i) the world largest collection of Gateway entry clones, (ii) arrangement of both N-and F-type entry clones, and especially, (iii) SDS-PAGE patterns of proteins expressed in the cell-free wheat germ extract system ('PE' shown in Figure 1 ).
Gateway entry clones
To facilitate utilization of full-length cDNA clones, we have adopted the versatile Gateway expression system which offers high-throughput gene transfer technology for functional gene analysis and protein expression.
For conversion to entry clones, we selected an ORF region in each cDNA meeting one of the following criteria: (i) ORFs-encoding products 150 aa [although the longest ORF starting with an AUG codon has highest priority, the selected ORF is finally determined by taking into consideration homology search results of shorter ORFs with BLASTX(nr) and BLASTP against SwissProt and RefSeq databases); (ii) both '149 aa ORF 100 aa' and 'ORF with an ATGpr value (17) 0.4'; (iii) both '100 aa >ORF' and 'known gene'. Those ORF regions were PCR amplified with attB sequences of the Gateway system at both ends. Then those fragments were recombined with attP sequences of the Gateway donor vector pDONR201 (Invitrogen). Eventually, we constructed 33 275 Gateway entry clones utilizing FLJ clones as major cDNA resources. Sequence information, such as amino acid and nucleotide sequences of ORF regions and sequence differences of Gateway entry clones from source cDNAs are presented in the 'GW: Gateway Summary' page (for help, see http:// hgpd.hinv.jp/sys_info/help.html#w120_gw). The details for construction and usage of entry clones will be published elsewhere (18) .
Gateway entry clones are available from NITE Biological Resource Center (NBRC), Department of Biotechnology, National Institute of Technology and Evaluation. Distribution of clones by NBRC requires the signing of an MTA by both private companies and academic institutions. Distribution charges will be 30 000 and 15 000 Yen (JPN; approx. US$300 and $150, respectively) per clone for private companies and academic institutions, respectively. More information is available through the 'clone inquiry' page (http://hgpd.hinv.jp/sys_info/order_clone. html) of HGPD or the notice page (http://www.nbrc. nite.go.jp/e/hgentry-e.html) of NBRC.
SDS-PAGE patterns of human proteins synthesized in vitro
The Gateway system is a versatile expression vector system that is adequate for handling large numbers of clones. For expression of large numbers of human proteins, we adopted the wheat germ cell-free protein synthesis system. In addition, we devised a new procedure to prepare template DNA for transcription, which makes the step simpler and more efficient. By applying those protocols, we expressed 13 364 human proteins with a C-terminal V5 or His tag and analyzed them using SDS-PAGE. Expression patterns of proteins in both the total and supernatant fractions are displayed in the 'PE: Protein Expression' page (for details, see http://hgpd.hinv.jp/sys_info/help. html#w120_pe). Essentially all of the human proteins analyzed in our work were shown to be expressed. This implies that in vitro cell-free systems using wheat germ extract offer a very efficient system for protein production.
Computational analysis of individual cDNA sequences with BLAST, Pfam, PROSITE, PSORT, SignalP, SOSUI and GO Functional motifs and domains, subcellular localization information, leader sequences and transmembrane 
Mapping and clustering of cDNA clones
Local alignments between human cDNAs and human genome sequences (UCSC hg17 NCBI Build 35) were calculated using megablast (http://www.ncbi.nih.gov/blast). Initially, the alignment with the highest score was selected and a single locus was assigned for each cDNA. Those cDNAs with sequences overlapping not less than 1 base at the same locus and strand were defined as constituting the same cluster. All entries cataloged in HGPD are presented in Table 1 .
WEB INTERFACE
The search flow of HGPD is illustrated in Figure 1 Data for amino acid and nucleotide sequences of ORFs cloned into Gateway entry clones, summary of protein expression and others can be downloaded from the top page of HGPD (http://hgpd.hinv.jp/sys_info/download. html).
FUTURE DEVELOPMENTS
Several modifications in browser interface will be done. (i) The database will be updated by next spring to correspond to UCSC hg18/NCBI build 36. (ii) Various search interfaces will be introduced in a future version.
Information on about 18 000 more human entry clones will be included shortly, which will put the cumulative number of our collection at 50 000. Fourteen thousand entries on protein expression data in Escherichia coli will also be presented in HGPD. Additionally, data for subcellular localization for 14 000 expressed human proteins, which have been examined in HeLa cells, are being processed for publication. 
